A panelist discusses how integrating clinical trial data with real-world experience, patient-centered care, and shared decision-making enables retina specialists to individualize treatment plans, optimize adherence, and preserve vision in patients with geographic atrophy and neovascular AMD.
A panelist discusses how interpreting clinical trial data, monitoring disease progression, and maintaining transparent communication help retina specialists make informed decisions about when and how to treat geographic atrophy with emerging therapies.
A panelist discusses how retina specialists, residents, and fellows manage geographic atrophy by emphasizing early diagnosis, navigating new anticomplement therapies, and improving patient communication to build confidence and personalize treatment in evolving clinical settings.
